Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 345

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis

Open access
Lacas, Benjamin, Bourhis, Jean, Overgaard, Jens, Zhang, Qiang, Grégoire, Vincent, Nankivell, Matthew, Zackrisson, Björn, Szutkowski, Zbigniew, Suwiński, Rafał, Poulsen, Michael, O'Sullivan, Brian, Corvò, Renzo, Laskar, Sarbani Ghosh, Fallai, Carlo, Yamazaki, Hideya, Dobrowsky, Werner, Cho, Kwan Ho, Beadle, Beth, Langendijk, Johannes A, Viegas, Celia Maria Pais, Hay, John, Lotayef, Mohamed, Parmar, Mahesh K B, Aupérin, Anne, van Herpen, Carla, Maingon, Philippe, Trotti, Andy M, Grau, Cai, Pignon, Jean-Pierre, Blanchard, Pierre, Blanchard, Pierre, Bourhis, Jean, Lacas, Benjamin, Pignon, Jean Pierre, Bernier, Jacques, Le, Quynh-Thu, Overgaard, Jens, Parmar, Masheh KB, Trotti, Andy, Agarwal, Jai Prakash, Aupérin, Anne, Ang, Kian K, Awwad, Hassan K, Bacigalupo, Almalina, Bartelink, Harry, Benhamou, Ellen, Bernier, Jacques, Blanchard, Pierre, Bourhis, Jean, Budach, Wilfried, Chitapanarux, Imjai, Cho, Kwan Ho, Collette, Laurence, Corvò, Renzo, Dani, Carla, Dische, Stanley, Dobrowsky, Werner, Denham, James W, Driessen, Chantal ML, Fallai, Carlo, Beadle, Beth, Laskar, Sarbani Ghosh, Ghoshal, Sushmita, Grau, Cai, Gregoire, Vincent, Hay, John H, van Herpen, Carla, Hliniak, Andrzej, Johansen, Jørgen, Kristiansen, Claus Andrup, Krstevska, Valentina, Lacas, Benjamin, Langendijk, Johannes A., Lapeyre, Michel, Le, Quynh-Thu, Lotayef, Mohamed, Maciejewski, Boguslaw, Maingon, Philippe, Michalski, Wojciech, Moon, Sung Ho, Nilsson, Per, Olmi, Patrizia, Nankivell, Matthew, Nishiyama, Kinji, O'Sullivan, Brian, Overgaard, Jens, Parmar, Mahesh KB, Pignon, Jean-Pierre, Poulsen, Michael G, Ramadas, Kunnambath, Rishi, Anupam, Rosenthal, David I., Sanguineti, Giuseppe, Saunders, Michele I, Sire, Christian, Skladowski, Krzysztof, Souhami, Luis, Suwinski, Rafal, Szutkowski, Zbigniew, Tandon, Nitin, van Tinteren, Harm, Torri, Valter, Tripcony, Lee, Trotti, Andy, Viegas, Celia Maria Pais, Waldron, John, Widder, Joachim, Wong, Stuart, Wu, Jonn S, Yamazaki, Hideya, Zackrisson, Björn, Zhang, Qiang · 2017 · The Lancet Oncology

Abstract

Summary Background The Meta-Analysis of Radiotherapy in squamous cell Carcinomas of Head and neck (MARCH) showed that altered fractionation radiotherapy is associated with improved overall and progression-free survival compared with conventional radiotherapy, with hyperfractionated radiotherapy showing the greatest benefit. This update aims to confirm and explain the superiority of hyperfractionated radiotherapy over other altered fractionation radiotherapy regimens and to assess the benefit of altered fractionation within the context of concomitant chemotherapy with the inclusion of new trials. Methods For this updated meta-analysis, we searched bibliography databases, trials registries, and meeting proceedings for published or unpublished randomised trials done between Jan 1, 2009, and July 15, 2015, comparing primary or postoperative conventional fractionation radiotherapy versus altered fractionation radiotherapy (comparison 1) or conventional fractionation radiotherapy plus concomitant chemotherapy versus altered fractionation radiotherapy alone (comparison 2). Eligible trials had to start randomisation on or after Jan 1, 1970, and completed accrual before Dec 31, 2010; had to have been randomised in a way that precluded prior knowledge of treatment assignment; and had to include patients with non-metastatic squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx undergoing first-line curative treatment. Trials including a non-conventional radiotherapy control group, investigating hypofractionated radiotherapy, or including mostly nasopharyngeal carcinomas were excluded. Trials were grouped in three types of altered fractionation: hyperfractionated, moderately accelerated, and very accelerated. Individual patient data were collected and combined with a fixed-effects model based on the intention-to-treat principle. The primary endpoint was overall survival. Findings Comparison 1 (conventional fractionation radiotherapy vs altered fractionation radiotherapy) included 33 trials and 11 423 patients. Altered fractionation radiotherapy was associated with a significant benefit on overall survival (hazard ratio [HR] 0·94, 95% CI 0·90–0·98; p=0·0033), with an absolute difference at 5 years of 3·1% (95% CI 1·3–4·9) and at 10 years of 1·2% (−0·8 to 3·2). We found a significant interaction (p=0·051) between type of fractionation and treatment effect, the overall survival benefit being restricted to the hyperfractionated group (HR 0·83, 0·74–0·92), with absolute differences at 5 years of 8·1% (3·4 to 12·8) and at 10 years of 3·9% (−0·6 to 8·4). Comparison 2 (conventional fractionation radiotherapy plus concomitant chemotherapy versus altered fractionation radiotherapy alone) included five trials and 986 patients. Overall survival was significantly worse with altered fractionation radiotherapy compared with concomitant chemoradiotherapy (HR 1·22, 1·05–1·42; p=0·0098), with absolute differences at 5 years of −5·8% (−11·9 to 0·3) and at 10 years of −5·1% (−13·0 to 2·8). Interpretation This update confirms, with more patients and a longer follow-up than the first version of MARCH, that hyperfractionated radiotherapy is, along with concomitant chemoradiotherapy, a standard of care for the treatment of locally advanced head and neck squamous cell cancers. The comparison between hyperfractionated radiotherapy and concomitant chemoradiotherapy remains to be specifically tested.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1470-2045(17)30458-8

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 37 references

Cited by

See all 345

Metadata

Authors
Lacas, B., Bourhis, J., Overgaard, J., Zhang, Q., Grégoire, V., Nankivell, M., Zackrisson, B., Szutkowski, Z., Suwiński, R., Poulsen, M., O'Sullivan, B., Corvò, R., Laskar, S. G., Fallai, C., Yamazaki, H., Dobrowsky, W., Cho, K. H., Beadle, B., Langendijk, J. A., Viegas, C. M. P., Hay, J., Lotayef, M., Parmar, M. K. B., Aupérin, A., van Herpen, C., Maingon, P., Trotti, A. M., Grau, C., Pignon, J.-P., Blanchard, P., Blanchard, P., Bourhis, J., Lacas, B., Pignon, J. P., Bernier, J., Le, Q.-T., Overgaard, J., Parmar, M. K., Trotti, A., Agarwal, J. P., Aupérin, A., Ang, K. K., Awwad, H. K., Bacigalupo, A., Bartelink, H., Benhamou, E., Bernier, J., Blanchard, P., Bourhis, J., Budach, W., Chitapanarux, I., Cho, K. H., Collette, L., Corvò, R., Dani, C., Dische, S., Dobrowsky, W., Denham, J. W., Driessen, C. M., Fallai, C., Beadle, B., Laskar, S. G., Ghoshal, S., Grau, C., Gregoire, V., Hay, J. H., van Herpen, C., Hliniak, A., Johansen, J., Kristiansen, C. A., Krstevska, V., Lacas, B., Langendijk, J. A., Lapeyre, M., Le, Q.-T., Lotayef, M., Maciejewski, B., Maingon, P., Michalski, W., Moon, S. H., Nilsson, P., Olmi, P., Nankivell, M., Nishiyama, K., O'Sullivan, B., Overgaard, J., Parmar, M. K., Pignon, J.-P., Poulsen, M. G., Ramadas, K., Rishi, A., Rosenthal, D. I., Sanguineti, G., Saunders, M. I., Sire, C., Skladowski, K., Souhami, L., Suwinski, R., Szutkowski, Z., Tandon, N., van Tinteren, H., Torri, V., Tripcony, L., Trotti, A., Viegas, C. M. P., Waldron, J., Widder, J., Wong, S., Wu, J. S., Yamazaki, H., Zackrisson, B., & Zhang, Q.
Venue
The Lancet Oncology
Publisher
Elsevier BV
Published
2017-09
Volume
18
Issue
9
Pages
1221-1237
ISSN
1470-2045 (ISSN-L)
OpenAlex
W2740402187
Cited by
345
References
37
FWCI
27.19
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis. https://app.cochat.ai/papers/10.1016/s1470-2045(17)30458-8
The paper
Lacas, B., Bourhis, J., Overgaard, J., Zhang, Q., Grégoire, V., Nankivell, M., Zackrisson, B., Szutkowski, Z., Suwiński, R., Poulsen, M., O'Sullivan, B., Corvò, R., Laskar, S. G., Fallai, C., Yamazaki, H., Dobrowsky, W., Cho, K. H., Beadle, B., Langendijk, J. A., . . . Zhang, Q. (2017). Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis. The Lancet Oncology. https://doi.org/10.1016/s1470-2045(17)30458-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.